Blair William & Co. IL Has $1.17 Million Position in Astera Labs, Inc. $ALAB

Key Points

• Blair William & Co. IL increased its stake in Astera Labs by 50.4%, holding 12,975 shares valued at approximately $1.17 million as of the end of the second quarter.
• Astera Labs reported a significant increase in revenue, reaching $191.93 million for the quarter, up 149.5% from the previous year, along with an earnings per share of $0.44 that exceeded expectations.
• Several analysts have issued optimistic ratings, with price targets for Astera Labs ranging from $130.00 to $275.00, reflecting a consensus rating of "Moderate Buy" and an average price target of $159.83.

Blair William & Co. IL boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 50.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,975 shares of the company's stock after acquiring an additional 4,350 shares during the period. Blair William & Co. IL's holdings in Astera Labs were worth $1,173,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. US Bancorp DE increased its stake in shares of Astera Labs by 222.8% in the 2nd quarter. US Bancorp DE now owns 9,978 shares of the company's stock valued at $902,000 after purchasing an additional 6,887 shares during the last quarter. Rye Brook Capital LLC bought a new position in shares of Astera Labs in the 2nd quarter valued at $823,000. Maryland State Retirement & Pension System increased its stake in shares of Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company's stock valued at $629,000 after purchasing an additional 1,906 shares during the last quarter. Virtus Wealth Solutions LLC increased its stake in shares of Astera Labs by 81.6% in the 2nd quarter. Virtus Wealth Solutions LLC now owns 81,165 shares of the company's stock valued at $7,339,000 after purchasing an additional 36,465 shares during the last quarter. Finally, Venturi Wealth Management LLC bought a new position in shares of Astera Labs in the 2nd quarter valued at $289,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $161.46 on Thursday. The company has a market capitalization of $26.84 billion, a price-to-earnings ratio of 288.32, a P/E/G ratio of 4.03 and a beta of 1.43. The business's 50-day moving average is $200.21 and its 200-day moving average is $126.46. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same period in the previous year, the company posted $0.13 EPS. The firm's revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Needham & Company LLC lifted their price target on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Jefferies Financial Group raised their price objective on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Citigroup raised their price objective on Astera Labs from $160.00 to $275.00 and gave the company a "buy" rating in a report on Wednesday, September 17th. CICC Research started coverage on Astera Labs in a report on Friday, August 29th. They set an "outperform" rating and a $190.00 price objective on the stock. Finally, TD Cowen started coverage on Astera Labs in a report on Wednesday, October 1st. They set a "hold" rating and a $200.00 price objective on the stock. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $159.83.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 10,000 shares of the business's stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares of the company's stock, valued at $29,126,267.68. The trade was a 6.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Sanjay Gajendra sold 91,441 shares of the business's stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares of the company's stock, valued at $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,228,269 shares of company stock worth $206,885,610 over the last three months. Insiders own 12.50% of the company's stock.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.